Frontier Biotechnologies Inc.

¥13.28As of Sun 8 Nov 2026, 12:00 UTC
SSE:688221Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (10.08%)
Div yield —
ROE (3.69%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.06
PE TTM —
TSR TTM (16.69%)
Mkt cap ¥4.974B
ROIC (2.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
20.99%
(17.16%)
Hold 11|12|11|7|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.19
0.20
0.21
4.32%
5.24%
15.58%
23.00%
Revenue¥M
256.8
261.3
276.6
277.1
9.99%
8.81%
12.40%
6.83%
Peers (US$745.7M)
Cap (US$)
PE
776.3M
21.45x
755.8M
21.45x
752.8M
31.66x
746.9M
12.54x
Capital
TTM
5Y
10Y
Leveragex
0.156
0.147
0.119
EBIT/Intx
1.078
0.068
0.065
Own earn%
(93.45)
(21.23)
(22.94)
Sh yield%
27.22
22.88
22.38
Owners
Insiders/Inst%
8.65
70.14
Short interest%
2.58
SBC / revenue%
1.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
31–35
$1 testx
−0.1
Incr. ROIC%
41